Addressing underlying causes is key
doi: 10.1016/j.ajpath.2012.07.015 58 VendrellJEl BekayRPeralBGarca-FuentesEMegiaAMacias-GonzalezMet al
MeAgains GLP-1 app tracks doses and symptoms, providing valuable tools for managing medication safely
For many people, thats a key distinctionbut responses vary, and this therapy is not one-size-fits-all
Novel localization of OCTN1, an organic cation/carntine transporter to mammalian mitochondria
1 2 American Academy of Dermatology (February 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation , American Academy of Dermatology, archived from the original on 1 December 2013, retrieved 5 December 2013, which cites: al